Published in Biochem Biophys Res Commun on November 15, 1989
Selectins. J Clin Invest (1993) 3.98
Selectin ligands. Proc Natl Acad Sci U S A (1994) 3.66
From carbohydrate leads to glycomimetic drugs. Nat Rev Drug Discov (2009) 2.13
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest (1998) 1.97
The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med (1999) 1.76
Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol (1994) 1.38
Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med (1992) 1.28
Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci U S A (1991) 1.28
Higher-affinity oligosaccharide ligands for E-selectin. J Clin Invest (1993) 1.07
Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci U S A (1996) 0.99
Differential inhibition of polymorphonuclear leukocyte recruitment in vivo by dextran sulphate and fucoidan. Mediators Inflamm (1996) 0.75
Separation of important new platelet glycoproteins (GPIa, GPIc, GPIc*, GPIIa and GMP-140) by f.p.l.c. Characterization by monoclonal antibodies and gas-phase sequencing. Biochem J (1991) 0.75
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (1990) 5.28
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A (1990) 4.59
Complete covalent structure of human beta-thromboglobulin. Biochemistry (1978) 2.64
The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (2001) 2.41
Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31
Bernard-Soulier syndrome. Blood (1998) 2.29
The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med (1999) 1.76
Rat aortic stenting: toward a simple model of in-stent restenosis. Am J Cardiol (2001) 1.75
Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol (1991) 1.68
GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem (1991) 1.62
New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med (1999) 1.58
Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science (1990) 1.54
The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost (2001) 1.53
Clinical analysis of 125 patients with the lupus anticoagulant. Aust N Z J Med (1993) 1.49
PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci (1999) 1.47
Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol (1997) 1.46
Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemost (1993) 1.46
Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin. J Am Coll Cardiol (1990) 1.44
Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease. J Thromb Haemost (2008) 1.42
Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost (2007) 1.41
Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem (1985) 1.40
Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem (1997) 1.40
Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem (2000) 1.39
Glycoprotein Ib-IX-V. Int J Biochem Cell Biol (2003) 1.38
Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 1.37
Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. J Biol Chem (1990) 1.36
Structure of the glycoprotein Ib.IX complex from platelet membranes. J Biol Chem (1988) 1.35
Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet (1986) 1.34
Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34
Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34
Uses of heparin. BMJ (1993) 1.31
A novel approach to the assessment of variations in the human platelet count. Thromb Haemost (2000) 1.31
An apparatus for simultaneous manual solid-phase synthesis of multiple peptide analogs. Anal Biochem (1984) 1.29
Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol (1989) 1.29
P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem (1995) 1.29
Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model. J Cell Biol (1999) 1.29
Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med (1992) 1.28
Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci U S A (1991) 1.28
Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28
Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol (2001) 1.27
PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity (1999) 1.27
Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain. J Gen Virol (1987) 1.26
Identification of a membrane skeleton in platelets. J Cell Biol (1988) 1.25
Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem (1981) 1.24
Binding of the von Willebrand factor A1 domain to histone. Thromb Res (1997) 1.21
Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood (1989) 1.21
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem (2000) 1.21
A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem (1995) 1.21
Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood (1995) 1.21
Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Biochemistry (1998) 1.21
P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19
Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry (1989) 1.18
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study. Thromb Haemost (2001) 1.17
Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood (1996) 1.17
Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells. J Immunol (1994) 1.16
Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood (1994) 1.16
A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16
Purification of antiphospholipid antibodies using a new affinity method. Thromb Res (1988) 1.15
The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol (2001) 1.15
P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med (1994) 1.14
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol (1993) 1.14
Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood (1987) 1.13
Urea and urease. Adv Inorg Biochem (1984) 1.13
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med (1990) 1.13
The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets. J Thromb Haemost (2004) 1.13
The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem (1993) 1.13
Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost (2005) 1.12
Additional glycoprotein defects in Bernard-Soulier's syndrome: confirmation of genetic basis by parental analysis. Blood (1983) 1.11
Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood (1995) 1.11
Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta. Blood (2000) 1.11
Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol Cell (2000) 1.10
A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem (1992) 1.10
Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med (2001) 1.10
Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol (1999) 1.10
Human beta-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature (1979) 1.09
Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation (1994) 1.05
Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood (1996) 1.05
Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules. J Immunol (2000) 1.04
Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response. Mol Cell Proteomics (2004) 1.04
Activation of the 43 kDa inositol polyphosphate 5-phosphatase by 14-3-3zeta. Biochemistry (1997) 1.03
Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem (1997) 1.03
Characterization of a novel membrane glycoprotein involved in platelet activation. J Biol Chem (1989) 1.03
Hyperinducible gene expression from a metallothionein promoter containing additional metal-responsive elements. Gene (1989) 1.03